The Ophthalmologist Power List 2014
January 29, 2014
Ranking the 100 most influential people in ophthalmology
1 min read
False
Advertisement
Jan
Six Strategies to Stimulate Resident Learning
January 22, 2014
Academic ophthalmologists are expected to be effective teachers but receive little or no instruction on teaching methodology. Our goal should not be to teach; rather, for the student to learn what is needed. These tips will improve your effectiveness.
1 min read
Re-engineering Healthcare
January 22, 2014
Change is hard – and major change even more so – in large part for one simple reason: as Leo Tolstoy once advised, “Everyone thinks of changing the world, but no one thinks of changing himself.”
1 min read
Right place, right time
January 21, 2014
Sitting Down With Carrie MacEwen, Consultant Ophthalmologist at Ninewells Hospital, Dundee, Scotland, and President-Elect of the UK Royal College of Ophthalmologists
1 min read
Integrin Blockade as a Retinovascular Therapy
January 21, 2014
A new drug, ALG-1001, that blocks the transmembrane receptors that cells use to attach to their surroundings, has the potential to treat a range of retinovascular diseases
1 min read
Gene Therapy Clinical Trials
January 21, 2014
The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?
1 min read
A Novel Refractive Procedure for Keratoconus
January 20, 2014
Intracorneal ring segment and phakic IOL implantation: a refractive solution for patients with keratoconus and high myopia
1 min read
Ten Tips for Toric Lens Implantation
January 20, 2014
Practical pearls and possible pitfalls for the general cataract surgeon
1 min read
DMEK Simplified, Deftly
January 20, 2014
A novel method for preparation of Descemet membrane endothelial keratoplasty (DMEK) grafts is here. It uses a punch but doesn’t lay a finger (or forceps) on the corneal endothelial cells.
1 min read
VEGF has Physiolgical as well as Pathological Functions
January 20, 2014
Growing evidence for the key role played by VEGF in the normal adult eye now demands that ophthalmologists give careful consideration to the use of anti-VEGF therapies. While these agents are highly effective for the treatment of ocular neovascularization – particularly as an anti-permeability factor – it may also interfere with the normal functions of VEGF in the eye.
1 min read
Browse by Subspecialties
False
Advertisement